A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma. Tan X, Shi L, Banerjee P, Liu X, et al. J Clin Invest 2021;131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tan X, Shi L, Banerjee P, Liu X, et al. A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma. J Clin Invest 2021;131.
PMID: 32931483